Phase Ib trial of oral CR 845 in healthy male volunteers.

Trial Profile

Phase Ib trial of oral CR 845 in healthy male volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 31 Aug 2012

At a glance

  • Drugs Difelikefalin (Primary)
  • Indications Pain
  • Focus Adverse reactions; Biomarker; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 31 Aug 2012 Results presented at the 14th World Congress on Pain.
    • 03 Apr 2012 Status changed from recruiting to completed, according to a Cara Therapeutics media release.
    • 22 Nov 2011 Status changed from planning to recruiting, according to a Cara Therapeutics media release
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top